INS and type 2 diabetes mellitus: Our meta‐analysis of six RCTs involving almost 4000 adults with type 2 diabetes demonstrates that once‐weekly insulin efsitora alfa provides glycemic efficacy comparable to once‐daily insulin, with similar reductions in HbA1c, fasting plasma glucose, body weight, and achievement of HbA1c targets.